A detailed history of Stonebrook Private Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stonebrook Private Inc. holds 14,870 shares of BMY stock, worth $852,497. This represents 0.2% of its overall portfolio holdings.

Number of Shares
14,870
Previous 16,663 10.76%
Holding current value
$852,497
Previous $692 Million 11.18%
% of portfolio
0.2%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $71,110 - $92,787
-1,793 Reduced 10.76%
14,870 $769 Million
Q2 2024

Aug 06, 2024

SELL
$40.25 - $52.99 $193,481 - $254,722
-4,807 Reduced 22.39%
16,663 $692 Million
Q1 2024

May 07, 2024

BUY
$47.98 - $54.4 $12,378 - $14,035
258 Added 1.22%
21,470 $1.16 Billion
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $1.03 Million - $1.23 Million
21,212 New
21,212 $1.09 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stonebrook Private Inc. Portfolio

Follow Stonebrook Private Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebrook Private Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stonebrook Private Inc. with notifications on news.